Dr Mukesh Hariawala to receive India’s Most Admired Surgeon 2012 award

Wednesday, August 1, 2012

Mumbai: US-based artificial heart surgeon Dr Mukesh Hariawala will receive India’s Most Admired Surgeon 2012 award at the 5th Annual Pharmaceutical Leadership Summit and Business Leadership Awards 2012 in Mumbai on September 21.

Dr Mukesh Hariawala

The event will be organised by healthcare bi-monthly magazine Pharma Leaders, in association with the union ministry of commerce and industries and the Pharmaceuticals Export Promotion Council of India (Pharmexcil).

Dr Hariawala has done pioneering research work in the field of cardiac angiogenesis, which is the spontaneous development of new blood vessels in the heart by laser stimulation and subsequent injection of patients own stem cells harvested from bone marrow.

“The medical world often finds itself clueless when it comes to providing treatment to the patients with terminal heart disease who are not candidates for routine angioplasty, stent or bypass surgery. Such patients can benefit only by transplantation, which is not a practical solution due to severe shortage of donor hearts. However, Titanium VAD (Ventricular Assist Devices), which functions as an ‘Artificial Heart’, can give them a new life,” said Dr Hariawala.

Categories: NEWS

Tags: , , ,

  More from NEWS

Next generation optical biometry devices market may grow to $450 million by 2028

Healthcare should be a mission with ethical & moral values: Rajnath Singh

Biosense Technologies raises $1 million in funding

World No Tobacco Day celebrated at ESIC Medical College

Pune doctors perform India’s first uterus transplant surgery

ICMR to test efficacy of two medicines for tackling drug-resistant TB

Comments »

No comments yet.

Name (required)
E-mail (required - never shown publicly)
Your Comment (smaller size | larger size)
You may use <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> in your comment.